4.5 Article

Acinetobacter baumannii reinforces the pathogenesis by promoting IL-17 production in a mouse pneumonia model

期刊

MEDICAL MICROBIOLOGY AND IMMUNOLOGY
卷 212, 期 1, 页码 65-73

出版社

SPRINGER
DOI: 10.1007/s00430-022-00757-2

关键词

IL-17; Neutrophil; Phagocytosis; A. baumannii

向作者/读者索取更多资源

This study investigated the role of interleukin-17 (IL-17) in pulmonary A. baumannii infection. The results showed that IL-17 promotes susceptibility of mice to A. baumannii infection by suppressing neutrophil phagocytosis.
Interleukin-17 (IL-17) is involved in host defense against bacterial infection. Little is known about the role of IL-17 in A. baumannii-infected pneumonia. Our objective was to investigate the role of IL-17 in pulmonary A. baumannii infection in a mouse model. We infected C57BL/6 mice intra-tracheally (i.t.) with A. baumannii to establish pneumonia model and found A. baumannii infection elevated IL-17 expression in lungs. IL-17-deficient (Il17(-/-)) mice were resistant to pulmonary A. baumannii infection, showing improved mice survival, reduced bacteria burdens, and alleviated lung inflammation. Further, treatment of A. baumannii-infected Il17(-/-) mice with IL-17 exacerbated the severity of pneumonia. These data suggest a pathogenic role of IL-17 in pulmonary A. baumannii infection. Further, the infiltration and phagocytic function of neutrophils in broncho-alveolar lavage fluid were detected by flow cytometry. The results showed that Il17(-/-) mice had increased neutrophil infiltration and enhanced phagocytosis in neutrophils at the early time of infection. Treatment of mice with IL-17 suppressed phagocytic function of neutrophils. All data suggest that IL-17 promotes susceptibility of mice to pulmonary A. baumannii infection by suppressing neutrophil phagocytosis at early time of infection. Targeting IL-17 might be a potential therapeutic strategy in controlling the outcome of A. baumannii pneumonia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据